• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Mol Immunol . A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence an

tetano

Editor, Senior Moderator
Cell Mol Immunol


. 2020 Oct 9.
doi: 10.1038/s41423-020-00550-2. Online ahead of print.
A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract


Fengyu Hu[SUP] 1 [/SUP], Fengjuan Chen[SUP] 1 [/SUP], Zhihua Ou[SUP] 2 [/SUP], Qinghong Fan[SUP] 1 [/SUP], Xinghua Tan[SUP] 1 [/SUP], Yaping Wang[SUP] 1 [/SUP], Yuejun Pan[SUP] 1 [/SUP], Bixia Ke[SUP] 3 [/SUP], Linghua Li[SUP] 1 [/SUP], Yujuan Guan[SUP] 1 [/SUP], Xiaoneng Mo[SUP] 1 [/SUP], Jian Wang[SUP] 1 [/SUP], Jinlin Wang[SUP] 1 [/SUP], Chun Luo[SUP] 1 [/SUP], Xueliang Wen[SUP] 1 [/SUP], Min Li[SUP] 2 4 [/SUP], Peidi Ren[SUP] 2 [/SUP], Changwen Ke[SUP] 3 [/SUP], Junhua Li[SUP] 2 5 [/SUP], Chunliang Lei[SUP] 6 [/SUP], Xiaoping Tang[SUP] 7 [/SUP], Feng Li[SUP] 8 [/SUP]



Affiliations
Free article

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been redetected after discharge in some coronavirus disease 2019 (COVID-19) patients. The reason for the recurrent positivity of the test and the potential public health concern due to this occurrence are still unknown. Here, we analyzed the viral data and clinical manifestations of 289 domestic Chinese COVID-19 patients and found that 21 individuals (7.3%) were readmitted for hospitalization after detection of SARS-CoV-2 after discharge. First, we experimentally confirmed that the virus was involved in the initial infection and was not a secondary infection. In positive retests, the virus was usually found in anal samples (15 of 21, 71.4%). Through analysis of the intracellular viral subgenomic messenger RNA (sgmRNA), we verified that positive retest patients had active viral replication in their gastrointestinal tracts (3 of 16 patients, 18.7%) but not in their respiratory tracts. Then, we found that viral persistence was not associated with high viral titers, delayed viral clearance, old age, or more severe clinical symptoms during the first hospitalization. In contrast, viral rebound was associated with significantly lower levels of and slower generation of viral receptor-binding domain (RBD)-specific IgA and IgG antibodies. Our study demonstrated that the positive retest patients failed to create a robust protective humoral immune response, which might result in SARS-CoV-2 persistence in the gastrointestinal tract and possibly in active viral shedding. Further exploration of the mechanism underlying the rebound in SARS-CoV-2 in this population will be crucial for preventing virus spread and developing effective vaccines.

Keywords: SARS-CoV-2; gastrointestinal infection; protective antibody; virus recurrence.
 
Back
Top Bottom